Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC

BACKGROUND: Solute carrier family 7 member 2 (SLC7A2), a cationic amino acid transporter, is lowly expressed in ovarian and hepatocellular cancers, which is associated with their worse prognosis. However, its roles in the prognosis, drug resistance and immune infiltration in non-small-cell lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shanshan, Zou, Junrong, Dong, Jianyu, Shi, Huimian, Chen, Jie, Li, Yan, Duan, Xianglong, Li, Wensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838041/
https://www.ncbi.nlm.nih.gov/pubmed/36639771
http://dx.doi.org/10.1186/s12964-022-01023-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838041/
https://www.ncbi.nlm.nih.gov/pubmed/36639771
http://dx.doi.org/10.1186/s12964-022-01023-x

Ejemplares similares